
Sign up to save your podcasts
Or


We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease.
Interview-story link:
News links:
By NEJM Group4.5
5656 ratings
We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease.
Interview-story link:
News links:

7,599 Listeners

318 Listeners

2,059 Listeners

125 Listeners

496 Listeners

293 Listeners

885 Listeners

263 Listeners

3,340 Listeners

112,032 Listeners

90 Listeners

5 Listeners

92 Listeners

513 Listeners

2,548 Listeners

368 Listeners

15,832 Listeners

61 Listeners

31 Listeners

66 Listeners